Dergiler / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 4

Evaluation of GCF MMP-1, MMP-8, TGF-ß1, PDGF-AB, and VEGF levels in periodontally healthy smokers

Sayfa
850–856
Yayın Tarihi
2015-08-13
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Since increased levels of these molecules are involved in periodontal breakdown, our findings may emphasize the importance for maintenance of periodontal health in smokers.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: The effect of smoking on inflammatory biomarkers in gingival crevicular fluid (GCF) is well established in the presence of periodontal inflammation.
📊
Temel Bulgular & Veri:The aim of this study was to investigate GCF levels of MMP-1, MMP-8, transforming growth factor (TGF)-Ã1, platelet-derived growth factor (PDGF)-AB, and vascular endothelial growth factor (VEGF) in smoking versus nonsmoking periodontally healthy subjects.
💡
Sonuç & Katkı:Since increased levels of these molecules are involved in periodontal breakdown, our findings may emphasize the importance for maintenance of periodontal health in smokers.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Smoking · gingival crevicular fluid · matrix metalloproteinases

Abstract

Background/aim: The effect of smoking on inflammatory biomarkers in gingival crevicular fluid (GCF) is well established in the presence of periodontal inflammation. However, it is not clear if smoking has an influence on matrix metalloproteinase (MMP) and growth factor levels in the GCF of periodontally healthy subjects. The aim of this study was to investigate GCF levels of MMP-1, MMP-8, transforming growth factor (TGF)-Ã1, platelet-derived growth factor (PDGF)-AB, and vascular endothelial growth factor (VEGF) in smoking versus nonsmoking periodontally healthy subjects. Materials and methods: Thirty-two periodontally healthy subjects were included in this study. Probing depths, bleeding on probing, and plaque index was assessed. GCF levels of MMP-1, MMP-8, TGF-Ã1, PDGF-AB, and VEGF were analyzed by enzyme-linked immunosorbent assay. Results: No significant differences were observed in the distribution of demographic data between study groups. GCF total amount of PDGF-AB was significantly lower in smokers compared to nonsmokers (P = 0.014). Total amount of GCF MMP-1, MMP-8, TGF-Ã1, and VEGF levels were similar in both study groups (P = 0.022). Conclusion: Smoking has the effect of decreasing GCF PDGF-AB while it does not affect GCF MMP-1, MMP-8, TGF-Ã1, and VEGF in periodontally healthy subjects. Since increased levels of these molecules are involved in periodontal breakdown, our findings may emphasize the importance for maintenance of periodontal health in smokers.

🔖

Bu Makaleye Atıf Yap

EREN, G., TÜRKOĞLU, H. O., ATMACA, H., ATİLLA, F. G. (2015). Evaluation of GCF MMP-1, MMP-8, TGF-ß1, PDGF-AB, and VEGF levels in periodontally healthy smokers. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 4, 850–856. https://ajindex.com/articles/186175

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Cesar Neto JB, Ros EF, Pannuti CM, Romito GA. Smoking and periodontal tissues: a review. Braz Oral Res 2012; 26: 25–31.
  2. Javed F, Al-Askar M, Samaranayake LP, Al-Hezaimi K. Periodontal disease in habitual cigarette smokers and nonsmokers with and without prediabetes. Am J Med Sci 2013; 345: 94–98.
  3. Petrovic M, Kesic L, Obradovic R, Savic Z, Mihailovic D, Obradovic I, Avdic-Saracevic M, Janjic-Trickovic O, Janjic M. Comparative analysis of smoking influence on periodontal tissue in subjects with periodontal disease. Mater Sociomed 2013; 25: 196–198. Bergström J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989; 17: 245–247.
  4. Giannopoulou C, Kamma JJ, Mombelli A. Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 2003; 30: 145–153. 8. Bergström J. Tobacco smoking and risk for periodontal disease. J Clin Periodontol 2003; 30: 107–113. 9. Martinez-Canut P, Lorca A, Magàn R. Smoking and periodontal disease severity. J Clin Peridontondol 1995; 22: 743–749. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002; 29: 177–206.
  5. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996; 67: 675–681.
  6. Johannsen A, Susin C, Gustafsson A. Smoking and inflammation: evidence for a synergistic role in chronic disease. Periodontol 2000 2014; 64: 111–126.
  7. Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 2003; 31: 167–180.
  8. Sorsa T, Mäntylä P, Rönkä H, Kallio P, Kallis GB, Lundqvist C, Kinane DF, Salo T, Golub LM, Teronen O et al. Scientific basis of a matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann NY Acad Sci 1999; 878: 130–140.
  9. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997; 14: 144–157.
  10. Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mäntylä P. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006; 38: 306–321.
  11. Ryan ME, Ramamurthy S, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996; 3: 85–96.
  12. Sorsa T, Ingman T, Suomalai